Actively Recruiting
Bundled Cancer Screening and Genetic Services Navigation
Led by Georgetown University · Updated on 2026-05-08
820
Participants Needed
2
Research Sites
160 weeks
Total Duration
On this page
Sponsors
G
Georgetown University
Lead Sponsor
N
National Cancer Institute (NCI)
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this study is to test bundled familial cancer risk assessment + multicancer (colorectal + breast) vs. single (breast) cancer navigation, using a wait list control for colorectal cancer screening referral and navigation. Among those eligible, this study will test usual care referral to genetic services vs. pretest education + usual care referral. The study also will assess how bundled multicancer navigation works and for whom it is most effective through a multisite, mixed-methods patient- and organization-level process evaluation.
CONDITIONS
Official Title
Bundled Cancer Screening and Genetic Services Navigation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Seeking screening navigation services through programs at Georgetown Lombardi Cancer Center or Helen F. Graham Cancer Center & Research Institutes
- Eligible for breast cancer screening and due and eligible for colorectal cancer screening per USPSTF guidelines
- Female sex
- Aged 45 to 74 years
- Identify as Black/African American race and/or Hispanic/Latina ethnicity
- Speak English or Spanish with enough fluency to complete study activities
- Willing to comply with all study procedures and available for the study duration
- Provide completed electronic informed consent form
You will not qualify if you...
- Not engaged with or planning to use navigation programs at Georgetown Lombardi Cancer Center or Helen F. Graham Cancer Center & Research Institute
- Not eligible for breast cancer screening or not due and eligible for colorectal cancer screening per USPSTF guidelines
- History of breast or colorectal cancer or symptoms related to these cancers (e.g., GI bleeding, breast mass)
- Male sex, intersex, or other sex
- Under 45 or over 74 years old
- Do not identify as Black/African American or Hispanic/Latina ethnicity
- Do not speak English or Spanish fluently enough to complete study activities
- Unwilling to comply with study procedures or unavailable for study duration
- Unable to provide electronic informed consent or require another person to provide consent on their behalf
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
ChristianaCare-Helen F. Graham Cancer Center & Research Institute
Newark, Delaware, United States, 19713
Actively Recruiting
2
Georgetown University
Washington D.C., District of Columbia, United States, 20007
Actively Recruiting
Research Team
S
Suzanne O'Neill, PhD
CONTACT
C
Chiranjeev Dash, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SCREENING
Number of Arms
6
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here